Preparation and characterization of meselamine loaded PLGA nanoparticles

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 3, Issue 4, 2011, Pages 208-214

  Mahajan, N M ^a,b,c,d   Sakarkar, D M ^a,b,c,d   Manmode, A S ^a,b,c,d  

^a SGSPS Institute of Pharmacy   (India)

^b SN Institute of Pharmacy   (India)

^c SANT GADGE BABA AMRAVATI UNIVERSITY   (India)

^d Astron Research Ltd   (India)

Author keywords

Mesalamine; Modified SESD; Nanoparticles; PLGA; Ulcerative Colitis

Indexed keywords

MESALAZINE; NANOPARTICLE; POLY(DEXTRO,LEVO LACTIC CO GLYCOLIC ACID); POLYMER; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL ANALYSIS; CHEMICAL INTERACTION; DRUG RELEASE; EMULSION; ENCAPSULATION; IN VITRO STUDY; KINETICS; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; SYNTHESIS; X RAY DIFFRACTION; ZETA POTENTIAL;

EID: 80054865213     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Prakash, A., Markharm, A. Oral delayed release mesalazine: a review of its therapeutic potential in ulcerative colitis and Crohn's disease. Drugs. 1999; 57: 383-408.
2. Clemett, D., Markham, A. Prolonged-release mesalazine: a review of its therapeutic potential in ulcerative colitis and Crohn's disease. Drugs. 2000; 59: 929-956.
3. Loftus, E.V., Kane, S.V., Bjorkman, D. Systematic review: short-term adverse effects of 5-ASA agents in treatment of ulcerative colitis. Aliment. Pharmacol. Ther. 2004; 19: 179-189.
4. Lamprecht, A., Schafer, U., Lehr, C.M. Size-dependant bioadhesion of micro-and nanoparticulate carriers to the inflamed colonic mucosa. Pharm. Res. 2001; 18: 88-793.
5. Tabata, Y., Inoue, Y., Ikada, Y., Size effect on systemic and mucosal immune responses induced by oral administration of biodegradable microspheres. Vaccine.1996;14:1677-85.
6. Stein, J., Reis, J., Barrett, K.E., Disruption of intestinal barrier function associated with experimental colitis: possible role of mast cells. Am. J. Physiol. 1998; 274: G203-G209.
7. Alleman, E., Gurny, R., Doelker, E. Drug-loaded nanoparticles-preparation methods and drug targeting issues. Eur. J. Pharm. Biopharm. 1993; 39:173-191.
8. Davis, S.S. Colloids as drug-delivery systems. Pharm. Technol. 1981; 5: 71-88.
9. Davis, S.S., Illum, L., Moghimi, S.M. Microspheres for targeting drugs to specific body sites. J. Control. Release. 1993; 24: 157-163.
10. Couvreur, P., Fattal, E., Andremont, A. Liposomes and nanoparticles in the treatment of intracellular bacterial infections. Pharm. Res. 1991; 8: 1079-1086.
11. Couvreur, P., Fattal, E., Alphandary, H., Puisieux, Intracellular targeting of antibiotics by means of biodegradable nanoparticles. J. Control. Release. 1992; 19: 259-268.
12. Leroux, J.C., Allemann, E., Jaeghere, F.D., Doelker, E., Gurny, R. Biodegradable nanoparticles from sustained release formulations to improved site specific drug delivery. J. Control. Release. 1996; 39: 339-350.
13. Murakami H., Kobayashi M., Takeuchi H., Kawashima Y. Preparation of poly (DL-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method. Int. J. Pharm. 1999; 87: 143-152.
14. Sailaja A.K., Amareshwar P., Chakravarty P., Different techniques used for the preparation of nanoparticles using natural polymers and their application. Int. J. Pharm. Pharm. Sci. 2011; 3 (2): 45-50.
15. Muller R. H., Development of ascorbyl palmitate nanocrystals applying the nanosuspension technology. Int. J. pharm. 2008; 354: 227-234.
16. Snjezana S., PLGA nanoparticles prepared by Nanoprecipitation: Drug loading and release studies of water soluble drug. J. Control. Release. 1999; 57: 171-185.
17. Shah, S.S., Cha, Y., Pitt, C.G., Poly (glycolic acid-co-d, l-lactic acid): diffusion or degradation controlled drug delivery. J. Control. Release. 1992; 18: 261-270.
18. Coombes, A.G., Yeh, M.K., Lavelle, E.C., Davis, S.S. The control of protein release from PLGA microparticles by variation of the external aqueous phase surfactant in the water-in oil-in water method. J. Control. Release. 1998; 52: 311-320.
19. Pradeep B. et al., Formulation and evaluation of valacyclovir hydrochloride microcapsules. Int. J. Pharm. Pharm. Sci. 2011; 3 (2): 92-96.